Director Greenberger Participates in Association of American Law Schools' Panel "Risk and Regulation: Biosecurity and the Law"

Share this page:Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedInEmail this to someone

Biosecurity encompasses the efforts to limit the development and use of biological weapons, as well as the strategies to prevent or limit pandemic outbreaks. Legal and scientific efforts to curtail the malevolent use of pathogens (e.g., anthrax) or limit the occurrence of natural pandemics (e.g., influenza) necessarily overlap. Specific areas of current interest in biosecurity include the oversight of dual-use research in the life sciences, biosafety regulations on the use of specific pathogens in laboratory research, potential restrictions on the dissemination of research results with dual-use application, risk assessments of synthetic biology, the status of international governance mechanisms, such as the Biological Weapons Convention, the strengthening of public health surveillance mechanisms through the International Health Regulations, and the creation of international pandemic preparedness frameworks by the World Health Organization. CHHS Founder and Director Michael Greenberger will be present on a panel of legal scholars and scientists will discuss current legal issues in biosecurity, and consider how the legal and scientific efforts to prevent bioterrorism or limit infectious disease both converge and diverge.

Speakers:

Professor Michael Greenberger, University of Maryland Francis King Carey School of Law
Professor David P. Fidler, Indiana University Maurer School of Law
Professor Victoria Sutton, Texas Tech University School of Law
Professor Susan M. Wolf, University of Minnesota Law School
Arturo Casadevall, M.D., Ph.D., Albert Einstein College of Medicine, Bronx, NY

Print Friendly

Comments are closed.